News

Acurion Closes Oversubscribed $4.3 Million Seed Round to Advance AI-Driven Precision Oncology Platform

Funding led by TK Partners supports further clinical validation, regulatory preparation, and commercialization of OncoGaze™ SAN DIEGO, April 2, 2026 /PRNewswire/ — Acurion, a precision oncology technology company advancing AI-driven cancer biomarker detection through its […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Exactice Medical and ImSonic Announce Product Development and Supply Agreement for AIM Device in Transseptal Procedures

SAN DIEGO–(BUSINESS WIRE)–Exactice Medical, Inc. today announced a definitive agreement with ImSonic Medical, Inc. to complete advanced prototype development of its AIM device—the industry’s first combined imaging and transseptal access solution, designed to make transseptal […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026

SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will present new data at the American […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Spatial Biology

Spatial biology is a rapidly advancing discipline that examines biological molecules (such as DNA, RNA, and proteins) within their native locations in tissues. This approach offers critical insight into how cancer and immune cells interact […]

No Picture
News

Oncolytics Biotech® Completes Domicile Change to the United States

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) — Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced the completion of the previously announced change in the jurisdiction […]

No Picture
News

Calidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will present new data at the American […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment

SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today announced the nomination of a development candidate under its collaboration and exclusive worldwide license agreement […]

No Picture
News

Voro Therapeutics to Present New Preclinical Data on PrimeBody™ Platform and VOR-101 at Upcoming AACR 2026 and AET Europe Conferences

SAN DIEGO–(BUSINESS WIRE)– #AACR2026–Voro Therapeutics, a biotechnology company pioneering tumor-activated biologics to improve the safety and efficacy of cancer therapies, today announced upcoming oral presentations at the American Association for Cancer Research (AACR) Annual Meeting […]

News

Vetology Expands Public AI Validation Dashboard to 11 Metrics Per Classifier, Commits to Ongoing Model Retraining

Company publishes full statistical profiles for 89+ classifiers, reinforcing that building AI is only half the job. SAN DIEGO, April 1, 2026 /PRNewswire/ — Vetology, a provider of AI-generated radiology screening reports and board-certified veterinary […]